Back to 
BlackRock, Inc.
BlackRock, Inc.
FDMT7 quarters
Position history for BlackRock, Inc.'s holdings in 4D MOLECULAR THERAPEUTICS IN
BlackRock, Inc. holds 4.5M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $60.5M as of 2026-Q2. The position was increased (+9.7% shares). FDMT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$60.5M
Current Shares
4.5M
Total Value Change
+$33.1M
Total Shares Change
-375,262
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.